Late-chronic cardiotoxicity and heart failure caused by ibrutinib: a case report and literature review
Jian ZHU
Su-Yan BIAN
Department of Cardiology, the Second Medical Center, National Clinical Research Center of Geriatric Disease, Beijing Key Laboratory of Chronic Heart Failure Precision Medicine, Chinese PLA General Hospital, Beijing, China
摘要:Richter syndrome (RS) is a rare transformation of relatively.low-grade malignant chronic lymphocytic leukemia (CLL) tomore aggressive lymphoma.The most common form of RS is transformation to diffuse large B-cell lymphoma (> 95%) and much less frequently (< 1%) to Hodgkin lymphoma (HL), plasma blast lymphoma, or other rare lymphomas.[1] Once transformed, the prognosis is extremely poor with a median survival of five to fourteen months.[2] There are presently no standard salvage approaches for RS.
机标关键词:
论文发表日期:2021-04-28
在线出版日期:2025-08-15(本平台首次上网日期,不代表文献的发表时间)
页数:5( 307-311 )
老年心脏病学杂志(英文版)

老年心脏病学杂志(英文版)

SCICSCD
ISSN:1671-5411
年,卷(期):2021,18(4)
所属栏目:LETTER TO THE EDITOR